Please enter the email address you used to register, then we will send you a link to choose a new password
AGIO: 22% | Agios Pharmaceuticals shares are trading higher after the company announced its Phase 3 ENERGIZE study of Mitapivat met its primary and both key secondary endpoints.
SOFI: -5% | SoFi shares are trading lower after Keefe, Bruyette & Woods downgraded the stock from Market Perform to Underperform.
ABVC: 122% | ABVC BioPharma And Its Subsidiary Receive $460M From AiBtl BioPharma As The First Milestone Payment Of Global Licensing Fees
Posted In: ABVC AGIO SOFI